{"nct_id":"NCT01189929","title":"A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2010-08","start_date_type":null,"primary_completion_date":"2016-12","primary_completion_date_type":"ACTUAL","completion_date":"2016-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MREO"]}